Notably, SF3A3 has been shown to interact with MYC in breast cancer models, where translational modulation of SF3A3 induces metabolic reprogramming and acquisition of stem-like properties, ultimately potentiating MYC-driven oncogenesis in vivo [40]. Here, SF3A3 is linked to breast cancer.